Stocktoria

PRECIGEN, INC. PGEN

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2013-08-08 · LEI

PRECIGEN, INC. financials (annual)

Revenue
$190.9M $231.0M $151.2M $90.7M $32.0M $14.3M $26.9M $6.2M $3.9M $9.7M 2016201720182019202020212022202320242025
Net income
-$186.6M -$117.0M -$509.3M -$322.3M -$170.5M -$92.2M $28.3M -$95.9M -$126.2M -$250.6M 2016201720182019202020212022202320242025
Free cash flow
-$80.6M -$150.4M -$165.8M -$173.8M -$84.5M -$63.0M -$70.0M -$68.5M -$76.8M -$89.8M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$9.7M$3.9M$6.2M$26.9M$14.3M$32.0M$90.7M$151.2M$231.0M$190.9M
R&D expense$41.3M$53.1M$48.6M$404.6M$143.2M$112.1M
SG&A expense$70.1M$41.3M$40.4M$137.8M$146.1M$142.3M
Operating income-$110.5M-$135.0M-$99.8M-$505.6M-$137.9M-$125.2M
Interest expense$8.5M$611,000$861,000
Income tax$3,000-$1.8M-$458,000-$189,000-$160,000-$82,000-$930,000-$15.4M$2.1M-$3.9M
Net income-$250.6M-$126.2M-$95.9M$28.3M-$92.2M-$170.5M-$322.3M-$509.3M-$117.0M-$186.6M
EPS (diluted)$-1.37$-0.47$-0.39$0.14$-0.47$-1.02$-2.09
Operating cash flow-$87.8M-$68.2M-$66.9M-$65.0M-$55.8M-$77.0M-$135.9M-$124.2M-$103.7M-$49.0M
Free cash flow-$89.8M-$76.8M-$68.5M-$70.0M-$63.0M-$84.5M-$173.8M-$165.8M-$150.4M-$80.6M
Cash & equivalents$30.2M$29.5M$7.6M$4.9M$36.4M$51.8M$65.8M$96.9M$68.1M$62.6M
Total assets$155.5M$145.3M$151.0M$216.0M$359.9M$314.6M$455.8M$716.2M$846.9M$949.1M
Total liabilities$134.6M$78.5M$32.5M$89.7M$252.5M$247.4M$384.1M$337.5M$300.3M$379.8M
Shareholders' equity$20.9M$38.5M$118.5M$126.3M$107.3M$67.2M$71.7M$378.7M$546.5M$569.2M

Growth · year-over-year · Revenue CAGR -28.2%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+146.7%-36.9%-76.9%+88.6%-55.4%-64.7%-40.0%-34.5%+21.0%+10.0%
Net income growth-438.7%
EPS growth-378.6%
Free cash flow growth-451.7%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.